Sinovac Biotech, Ltd. SVA
6.47 USD 0.00 (+0.00%)
At closeOct 28, 2026, 4:00 PM EDT
6.47 Day range 6.47
6.47 52-week range 6.47
- YTD
- 0.00%
- 1 year
- 0.00%
Analyst view
Consensus: buy
Buy
Price target (mean) 3.52 -45.6% downside
Now 6.47
- Target (low)
- 1.50
- Target (mean)
- 3.52
- Target (high)
- 6.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | -0.03 | 0.0% | 0 | 0.0% | 2 |
| Next quarter | -0.02 | -0.03 – -0.02 | -0.04 | +50.0% | 0 | 0.0% | 2 |
| Current year | -0.11 | -0.11 – -0.10 | -0.13 | +15.4% | 0 | 0.0% | 3 |
| Next year | -0.12 | -0.13 – -0.10 | -0.11 | -9.1% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 20, 2014 | Morgan Stanley | Upgrade | — | Overweight |
| Nov 13, 2013 | Aegis Capital | Maintained | — | Buy |
| Aug 15, 2013 | Aegis Capital | Upgrade | Hold | Buy |
| May 15, 2013 | Morgan Stanley | Upgrade | Underperform | Equal-Weight |
| Mar 14, 2013 | Aegis Capital | Maintained | — | Hold |
| Dec 12, 2012 | Aegis Capital | Initiated | — | Hold |